Stentys Reports 2012 Financial Results

Published: Mar 28, 2013

STENTYS (FR0010949404 – STNT), a medical technology company commercializing, in Europe, the world's first and only Self-Apposing®stent to treat acute myocardial infarction (AMI), today announced its audited annual results for the 2012 financial year to 31 December 2012 as approved by the Board of Directors on 27 March 2013.

Back to news